PUBLICATIONS

We encourage our customers to acknowledge the work performed by MARGenomics. This can be done in the following way: Acknowledgment section: “The authors wish to thank [name of consultant(s) and/or unit)] of MARGenomics (Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain) for assistance with [services provided].” We will appreciate to receive notification of published research from our customers acknowledging MARGenomics.

Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis.
Martínez-Bosch N, Cristóbal H, Iglesias M, Gironella M, Barranco L, Visa L, et al.
EBioMedicine. 2022 Jan;75:103797.

Comorbidity between Alzheimer’s disease and major depression: a behavioural and transcriptomic characterization study in mice.
Martín-Sánchez A, Piñero J, Nonell L, Arnal M, Ribe EM, Nevado-Holgado A, et al.
Alzheimers Res Ther. 2021 04 2;13(1):73.

Signaling Transcriptome Is Upregulated in Type 2 Diabetes Mellitus.
Almanza-Aguilera E, Hernáez Á, Corella D, Sanllorente A, Ros E, Portolés O, et al. Cancer.
J Clin Med. 2020 Dec 29;10(1):E85.

Predictors of Good Outcome, Recurrence, or Progression in High-Grade T1 Non-Muscle-Invasive Bladder Cancer.
Bellmunt J, Kim J, Reardon B, Perera-Bel J, Orsola A, Rodriguez-Vida A, et al. Genomic.
Cancer Res. 2020 10 15;80(20):4476-86.

Association of Circulating microRNAs with Coronary Artery Disease and Usefulness for Reclassification of Healthy Individuals: The REGICOR Study.
Dégano IR, Camps-Vilaró A, Subirana I, García-Mateo N, Cidad P, Muñoz-Aguayo D, et al.
J Clin Med. 2020 05 9;9(5):E1402.

Oral premalignant lesions of smokers and non-smokers show similar carcinogenic pathways and outcomes. A clinicopathological and molecular comparative analysis.
de la Oliva J, Larque AB, Marti C, Bódalo-Torruella M, Nonell L, Nadal A, et al. Oral
J Oral Pathol Med.2021 Mar;50(3):280-6.

Transcriptome and cytogenetic profiling analysis of matched insitu/invasive cutaneous squamous cell carcinomas from immunocompetent patients.
García-Díez I, Hernández-Muñoz I, Hernández-Ruiz E, Nonell L, Puigdecanet E, Bódalo-Torruella M, Oral
J Oral Pathol Med.2021 Mar;50(3):280-6.

Expression profiling of microRNAs in human bone tissue from postmenopausal women.
De-Ugarte L, Serra-Vinardell J, Nonell L, Balcells S, Arnal M, Nogues X, et al.
Hum Cell. 2018 Jan;31(1):33-41.

Defining quantification methods and optimizing protocols for microarray hybridization of circulating microRNAs.
Garcia-Elias A, Alloza L, Puigdecanet E, Nonell L, Tajes M, Curado J, et al.
Sci Rep. 2017 08 10;7(1):7725.

Gene expression study and pathway analysis of histological subtypes of intestinal metaplasia that progress to gastric cancer.
Companioni O, Sanz-Anquela JM, Pardo ML, Puigdecanet E, Nonell L, García N, et al.
PLoS One. 2017;12(4):e0176043.

Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach.
Nomdedéu JF, Puigdecanet E, Bussaglia E, Hernández JJ, Carricondo M, Estivill C, et al.
Hematol Oncol. 2017 Dec;35(4):778-88.